Category Archives: Medical

NanoViricides commences synthesis of novel Ebola drug candidates

NanoViricides

NanoViricides, Inc., a nanomedicine company, announced on Tuesday that it has commenced synthesis of multiple novel anti-Ebola broad-spectrum drug candidates that are expected to work despite viral mutations. The company previously developed anti-Ebola drug candidates that demonstrated the validity and … Read More »

Emergent BioSolutions receives $29 million contract for next-generation anthrax vaccine

emergent_logo-300x124

Emergent BioSolutions, Inc., a specialty biopharmaceutical company, announced on Monday that it received a contract worth up to $29 million to develop a dry formulation of NuThrax, its next-generation anthrax vaccine candidate. The five-year contract with the National Institute of … Read More »

PharmAthene receives $28.1 million anthrax vaccine contract from NIAID

pharmathene

PharmAthene, Inc., a biodefense company, announced on Wednesday that it received a contract worth up to $28.1 million from the National Institute of Allergy and Infectious Diseases to develop a next-generation anthrax vaccine. PharmAthene will seek to develop an anthrax … Read More »

PharmAthene, Nanotherapeutics announce medical countermeasure alliance

pharmathene

PharmAthene, Inc., and Nanotherapeutics, Inc., announced on Monday that they formed an alliance to advance the development of medical countermeasures in the U.S. biodefense market. Under the agreement, each company will contribute expertise and resources in the hopes of advancing … Read More »

European Commission details Ebola response in memo

European Commission

The European Commission recently released a memo outlining the European Union’s response to the ongoing Ebola virus outbreak in West Africa. Since the outbreak began in, the European Commission has provided humanitarian aid and diplomatic assistance to the affected countries. … Read More »

Aeolus reports positive results from radiation exposure therapeutic

aeolus

Aeolus Pharmaceuticals, Inc., announced positive results on Thursday from a non-human primate study of its broad-spectrum catalytic antioxidant that demonstrated doubled survival rate following lung damage caused by acute radiation exposure. Researchers at the University of Maryland School of Medicine, … Read More »

Experts unsure how heroin in 2009-10 anthrax outbreak became infected

Anthrax

Researchers investigating the 2009-10 outbreak of injection anthrax in Scotland are still unaware of how the microbe ended up in heroin. It is widely believed, however, that either heroin wrapped in animal skins for trafficking purposes or a cutting agent … Read More »

HHS awards Ebola drug contract to Mapp Biopharmaceutical

DHHS

The Department of Health and Human Services announced on Tuesday that it will try to accelerate the development of a treatment for Ebola virus through a $24.9 million contract with Mapp Biopharmaceutical, Inc. The HHS Office of the Assistant Secretary … Read More »

PAHO/WHO recommends increased mosquito control to fight dengue, chikungunya

Aedes Mosquito

The Pan American Health Organization/World Health Organization (PAHO/WHO) advised on Friday that member states with Aedes mosquitoes within their borders take steps to reduce their numbers to prevent transmission of dengue fever and the chikungunya virus. PAHO/WHO said the notice … Read More »

CDC Director Frieden says Ebola epidemic is outpacing response

Tom Frieden

Tom Frieden, the director of the Centers for Disease Control and Prevention, announced on Tuesday that the Ebola virus outbreak in West Africa is outpacing current response and requires immediate action across nations. Frieden visited Sierra Leone, Liberia and Guinea … Read More »

Bavarian Nordic receives exercise of contract option for IMVAMUNE

800px-Bavarian_Nordic_logo.svg_

Bavarian Nordic A/S announced on Thursday that the Biomedical Advanced Research and Development Authority (BARDA) exercised an $118 million option for the continued delivery of IMVAMUNE smallpox vaccine to the Strategic National Stockpile. BARDA previously exercised a $100 million option … Read More »

Soligenix’s heat stable ricin toxin vaccine shows promise

f8k013111ex99i_soligenix0

Soligenix, Inc., a clinical-stage biopharmaceutical company, announced positive results on Tuesday from a preclinical study involving RiVax, the company’s ricin toxin vaccine. Using a non-human primate (NHP) lethal aerosol exposure model, the study found that subjects vaccinated with RiVax were … Read More »

WHO provides Ebola update for Senegal, Democratic Republic of Congo

225px-Flag_of_WHO.svg

The World Health Organization said on Friday that Senegal’s Ministry of Public Health and Social Affairs provided the WHO with details of a case of Ebola virus first reported on Thursday. The patient is 21-year-old man from Guinea who arrived … Read More »

NIH launching human testing of investigational Ebola vaccine

Ebola

The National Institutes of Health (NIH) said on Thursday that initial human testing of an investigational Ebola virus vaccine will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID). The vaccine, which was co-developed by NIAID … Read More »

CDC releases ebola management guidelines for first responders

140px-US_CDC_logo.svg

The Centers for Disease Control and Prevention released interim guidelines on Tuesday for first responders and managers of 911 Public Safety Answering Points (PSAPs) to manage patients known or suspected to have the Ebola virus. The CDC said that managers … Read More »